Impact of different subtypes of steatotic liver disease on immune checkpoint inhibitor-related drug-induced liver injury: a retrospective study
Hepatic steatosis is associated with an increased risk of PD-(L)1 inhibitor-related liver injury in patients with extrahepatic malignancies, particularly in the presence of multiple underlying aetiologies.
Authors
- Tinghuai Ma (ORCID: https://orcid.org/0000-0003-2320-1692)
- Huawei Yuan
- Haijia Bi
- Zhanfang Guo
- Mei Sun
- Yu Li
Institutions
- Dalian Medical University (CN)
- Dalian University of Technology (CN)
- Dalian Municipal Central Hospital (CN)
- Seventh People's Hospital of Dalian (CN)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1097/meg.0000000000003112
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00